Systematic review of 59 studies with meta-analysis: pooled prevalence of colorectal cancer screening among noncolorectal cancer survivors was 0.53, and survivors were more likely to be screened than cancer-free controls (OR 1.39), with possible publication bias.
Meta-analysisn = 59 studies
Bista et al. Colorectal Cancer Screening Among Noncolorectal Cancer Survivors: A Systematic Review and Meta-Analysis